Diabetes risk score: towards earlier detection of type 2 diabetes in general practice - PubMed (original) (raw)
Diabetes risk score: towards earlier detection of type 2 diabetes in general practice
S J Griffin et al. Diabetes Metab Res Rev. 2000 May-Jun.
Abstract
Background: Type 2 diabetes is common, costly and often goes unrecognised for many years. When patients are diagnosed, the majority exhibit associated tissue damage or established cardiovascular risk. Evidence is accumulating that earlier detection and management of diabetes and related metabolic abnormalities may be beneficial. We aimed to develop and evaluate a score based on routinely collected information to identify people at risk of having undetected diabetes.
Methods: A population-based sample of 1077 people, aged 40 to 64 years, without known diabetes, from a single Cambridgeshire general practice, underwent clinical assessment including an oral glucose tolerance test. In a separate 12-month study, 41 practices in southern England reported clinical details of patients aged 40 to 64 years with newly diagnosed Type 2 diabetes. A notional population was created by random selection and pooling of half of each dataset. Data were entered into a regression model to produce a formula predicting the risk of diabetes. The performance of this risk score in detecting diabetes was tested in an independent, randomly selected, population-based sample.
Results: Age, gender, body mass index, steroid and antihypertensive medication, family and smoking history contributed to the score. In the test population at 72% specificity, the sensitivity of the score was 77% and likelihood ratio 2.76. The area under the receiver-operating characteristic curve was 80%.
Conclusions: A simple score, using only data that are routinely collected in general practice, can help identify those at risk of diabetes. This score could contribute to efficient earlier detection through case-finding or targeted screening.
Copyright 2000 John Wiley & Sons, Ltd.
Similar articles
- Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Saaristo T, et al. Diab Vasc Dis Res. 2005 May;2(2):67-72. doi: 10.3132/dvdr.2005.011. Diab Vasc Dis Res. 2005. PMID: 16305061 - The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting.
Gray LJ, Taub NA, Khunti K, Gardiner E, Hiles S, Webb DR, Srinivasan BT, Davies MJ. Gray LJ, et al. Diabet Med. 2010 Aug;27(8):887-95. doi: 10.1111/j.1464-5491.2010.03037.x. Diabet Med. 2010. PMID: 20653746 - Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A. Franciosi M, et al. Diabetes Care. 2005 May;28(5):1187-94. doi: 10.2337/diacare.28.5.1187. Diabetes Care. 2005. PMID: 15855587 - A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
Barengo NC, Tamayo DC, Tono T, Tuomilehto J. Barengo NC, et al. Prim Care Diabetes. 2017 Feb;11(1):86-93. doi: 10.1016/j.pcd.2016.09.004. Epub 2016 Oct 7. Prim Care Diabetes. 2017. PMID: 27727004 - Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
Salinero-Fort MÁ, de Burgos-Lunar C, Mostaza Prieto J, Lahoz Rallo C, Abánades-Herranz JC, Gómez-Campelo P, Laguna Cuesta F, Estirado De Cabo E, García Iglesias F, González Alegre T, Fernández Puntero B, Montesano Sánchez L, Vicent López D, Cornejo Del Río V, Fernández García PJ, Sabín Rodríguez C, López López S, Patrón Barandío P; SPREDIA-2 Group. Salinero-Fort MÁ, et al. BMJ Open. 2015 Jul 28;5(7):e007195. doi: 10.1136/bmjopen-2014-007195. BMJ Open. 2015. PMID: 26220868 Free PMC article.
Cited by
- Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study.
Kunutsor SK, Khan H, Laukkanen JA. Kunutsor SK, et al. Diabetologia. 2015 May;58(5):961-7. doi: 10.1007/s00125-015-3520-0. Epub 2015 Feb 14. Diabetologia. 2015. PMID: 25680582 - The predictive value of resting heart rate in identifying undiagnosed diabetes in Korean adults: Korea National Health and Nutrition Examination Survey.
Park DH, Cho W, Lee YH, Jee SH, Jeon JY. Park DH, et al. Epidemiol Health. 2022;44:e2022009. doi: 10.4178/epih.e2022009. Epub 2022 Jan 3. Epidemiol Health. 2022. PMID: 34990528 Free PMC article. - Comparison of diabetes risk score estimates and cardiometabolic risk profiles in a middle-aged Irish population.
Phillips CM, Kearney PM, McCarthy VJ, Harrington JM, Fitzgerald AP, Perry IJ. Phillips CM, et al. PLoS One. 2013 Nov 13;8(11):e78950. doi: 10.1371/journal.pone.0078950. eCollection 2013. PLoS One. 2013. PMID: 24236074 Free PMC article. - Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.
Janghorbani M, Adineh H, Amini M. Janghorbani M, et al. Rev Diabet Stud. 2013 Winter;10(4):283-92. doi: 10.1900/RDS.2013.10.283. Epub 2014 Feb 10. Rev Diabet Stud. 2013. PMID: 24841881 Free PMC article. - Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA).
Damschroder LJ, Reardon CM, AuYoung M, Moin T, Datta SK, Sparks JB, Maciejewski ML, Steinle NI, Weinreb JE, Hughes M, Pinault LF, Xiang XM, Billington C, Richardson CR. Damschroder LJ, et al. Implement Sci. 2017 Jul 26;12(1):94. doi: 10.1186/s13012-017-0619-3. Implement Sci. 2017. PMID: 28747191 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical